Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.51 |
| ▸ | P2RY12 | Q9H244 | 6/20 | 0.45 |
| ▸ | BMPR1B | O00238 | 1/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.43 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.43 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26808193 | 1.00 | PRMT6 (0.51) | PRMT6P2RY12BMPR1BADORA1P2RY2 | |
| SCHEMBL19128087 | 0.94 | PRMT6 (0.51) | PRMT6P2RY12ADORA1 | |
| SCHEMBL19128052 | 0.94 | PRMT6 (0.51) | PRMT6P2RY12ADORA1 | |
| SCHEMBL29832174 | 0.94 | PRMT6 (0.51) | PRMT6P2RY12ADORA1 | |
| SCHEMBL19128447 | 0.94 | PRMT6 (0.51) | PRMT6P2RY12ADORA1 | |
| SCHEMBL25496501 | 0.93 | PRMT6 (0.50) | PRMT6P2RY12BMPR1BADORA1P2RY2 | |
| SCHEMBL26808462 | 0.93 | PRMT6 (0.50) | PRMT6P2RY12BMPR1BADORA1P2RY2 | |
| SCHEMBL29313491 | 0.91 | PRMT6 (0.50) | PRMT6P2RY12BMPR1BADORA1P2RY2 | |
| SCHEMBL13020577 | 0.91 | PRMT6 (0.49) | PRMT6P2RY12BMPR1BADORA1P2RY2 | |
| SCHEMBL13020643 | 0.90 | P2RY12 (0.51) | PRMT6P2RY12BMPR1BADORA1P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357306-A1 | SYNTHESIS OF 1,2,5-TRI-O-BENZOYL-3-DIBENZYLAMINO-3-DEOXYRIBOSE AS INTERMEDIATE FOR PRODUCING 3'-AMINO-3'-DEOXYADENOSINE AND 3'-AMINO-3'-DEOXYGUANOSINE AND THE PROTECTED DERIVATIVES THEREOF | BRISTOL MYERS SQUIBB CO (US) | 2023-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357306-A1 | SYNTHESIS OF 1,2,5-TRI-O-BENZOYL-3-DIBENZYLAMINO-3-DEOXYRIBOSE AS INTERMEDIATE FOR PRODUCING 3'-AMINO-3'-DEOXYADENOSINE AND 3'-AMINO-3'-DEOXYGUANOSINE AND THE PROTECTED DERIVATIVES THEREOF | STING1, CGAS, AMPD3 | PRMT6 2098/4885P2RY12 176/4885BMPR1B 1406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.